Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+1.55%)
As of: Oct 21, 2026 · 12:45 PM EDT

Jasper Therapeutics (JSPR) EBIT Margin (2021 - 2023)

Updated

Analysis

Jasper Therapeutics (JSPR) EBIT Margin (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 28.21%
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 37.86%
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 20.57%
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -133.21%
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 28.37%
10 Jasper Therapeutics 14.57 Mn -111.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -37,964.71%
Sep 30, 2022 -141,200.00%
Jun 30, 2021 -210,450.00%
Mar 31, 2021 -625,400.00%
API Access

Jasper Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=JSPR&period=max&api_key=YOUR_API_KEY